Chester County News and Community Website
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that its Chairman, CEO, and Co-founder, Dr. Shankar Musunuri, will deliver a key presentation at the 2025 Cell & Gene Meeting on …
Ocugen CEO to Present at Prestigious Cell & Gene Meeting on the Mediterranean Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced robust demand-led growth for its molluscum contagiosum treatment, YCANTH®, during the first quarter of 2025. The company reported a …
Verrica Pharmaceuticals Reports Strong First-Quarter Growth for YCANTH Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) has announced that its Founder and Chief Executive Officer, Wes Kaupinen, will take part in a fireside chat at the Jones Healthcare …
Palvella CEO to Present at Healthcare Innovation Conference Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced the appointment of Dr. Gavin Corcoran to its Board of Directors.
Verrica Pharmaceuticals Adds Dr. Gavin Corcoran to Board of Directors Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) will take center stage at the 15th World Congress of Pediatric Dermatology in Buenos Aires, Argentina, with a late-breaking oral presentation on …
Palvella Therapeutics Announces Late-Breaking Presentation at Global Pediatric Dermatology Congress Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) has announced that its 2025 Annual Meeting of Stockholders will take place on Tuesday, May 20, 2025, at 9:00 a.m. ET. For …
Vishay Intertechnology Announces Virtual 2025 Annual Meeting of Stockholders Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a dermatology-focused therapeutics company, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. Jayson Rieger, PhD, MBA, President and …
Verrica Pharmaceuticals to Present at Needham Healthcare Conference Read More
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) has received a notice from the New York Stock Exchange (NYSE) regarding its non-compliance with continued listing standards under Section 802.01B of the …
Annovis Bio Receives Non-Compliance Notice from NYSE Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) has announced that its Board of Directors has approved a regular quarterly dividend of $0.34 per share, scheduled for payment on April …
Omega Flex Declares $0.34 Quarterly Dividend for April 2025 Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced a definitive agreement to divest its International Pharmaceuticals business, operated primarily through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc. The deal, …
Endo, Inc. to Sell International Pharmaceuticals Business to Knight Therapeutics Read More